Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.21.2
Stock-Based Compensation (Tables)
9 Months Ended
Jun. 30, 2021
Stock-Based Compensation  
Schedule of fair value of stock options granted Valuation assumptions

Stock price

$

10.00

Exercise price

$

10.01

Dividend yield

 

0

%

Expected volatility

 

60

%

Risk-Free interest rate

 

0.63

%

Expected life (in years)

 

6.08

Schedule of stock option activities

    

    

    

    

Weighted 

    

Weighted

Average 

Weighted

 Average 

Remaining  

 Average

Grant Date 

Life

Intrinsic

Options

 Exercise Price

Fair Value

(years)

Value

Outstanding – October 1, 2020

9,859,674

$

0.19

$

0.20

6.8

$

Granted

 

10,920

 

10.01

 

5.49

 

  

 

  

Exercised

 

(66,123)

 

0.36

 

0.25

 

  

 

  

Forfeited

 

(114,645)

 

0.25

 

0.12

 

  

 

  

Outstanding – June 30, 2021

 

9,689,826

$

0.20

$

0.20

 

6.1

$

99,824

Exercisable as of June 30, 2021

 

9,683,001

$

0.19

$

0.20

 

6.1

$

99,818

Schedule of restricted stock

    

    

Weighted 

Average 

Shares of Restricted 

Grant Date 

Stock

Fair Value

Non-vested – October 1, 2020

 

$

Granted

 

790,497

 

10.00

Vested

 

(87,360)

 

10.00

Non-vested – June 30, 2021

 

703,137

$

10.00

Schedule of Stock-based compensation expense for stock options and restricted stock

For the Three Months Ended June 30,

    

2021

    

2020

Software development

$

86

$

7

General and administrative

 

2,425

 

77

Selling and marketing

 

7

 

6

Total stock-based compensation expense

$

2,518

$

90

For the Nine Months Ended June 30,

    

2021

    

2020

Software development

$

174

$

19

General and administrative

 

5,516

 

231

Selling and marketing

 

7

 

18

Total stock-based compensation expense

$

5,697

$

268